Evidence map›Paper›PMID 21785977›Full record

ArticleActa neuropathologica2011

Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice.

Michael R Hunsaker, Claudia M Greco, Marian A Spath, Arie P T Smits, Celestine S Navarro, Flora Tassone, Johan M Kros, Lies-Anne Severijnen, Elizabeth M Berry-Kravis, Robert F Berman and 4 more

Open access · greenAbstract readCase ReportsComparative Study
In one paragraph

Article in Acta neuropathologica, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 109 citations in OpenAlex.

  1. Memantine effects on verbal memory in fragile X-associated tremor/ataxia syndrome (FXTAS): a double-blind brain potential study.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Current advances in neuronal intranuclear inclusion disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Review
  8. Movement Disorders and the Gut: A Review.Movement disorders clinical practice · 2022
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Neuropathology ofBrain communications · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Women with Fragile X-associated Tremor/Ataxia Syndrome.Movement disorders clinical practice · 2020
    Article
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 2 countries.

Michael R HunsakerDepartment of Neurological Surgery, University of California, Davis, Davis, CA, USA.
Claudia M Greco
Marian A Spath
Arie P T Smits
Celestine S Navarro
Flora Tassone
Johan M Kros
Lies-Anne Severijnen
Elizabeth M Berry-Kravis
Robert F Berman
Paul J Hagerman
Rob Willemsen
Randi J Hagerman
Renate K Hukema
University of California, Davis · USErasmus MC · NLErasmus University Rotterdam · NLNeurological Surgery · USRadboud University Medical Center · NLRadboud University Nijmegen · NLRush University Medical Center · USUniversity of California Davis Medical Center · US

Funding

Restoring FMRP Phenotypes Frpm Temporal Regional and Splice- Isoforms VarationsP30HD002274 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 1985 to 2013
$33.6M
UC DAVIS CLINICAL AND TRANSLATIONAL SCIENCE CENTER: BPCAUL1RR024146 · NCRR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERGLUND, LARS F · 2006 to 2011
$27.0M
GENOTYPE/PHENOTYPE RELATIONSHIPS IN FRAGILE X FAMILIESR01HD036071 · NICHD · UNIVERSITY OF CALIFORNIA DAVIS · PI PAUL J HAGERMAN, RANDI J. HAGERMAN · 1998 to 2026
$13.8M
Characterization and Treatment of CNS Abnormalities in Premutation Carriers (4 ofRL1AG032115 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HAGERMAN, RANDI J. · 2007 to 2011
$5.8M
Trajectories and Markers of Neurodegeneration in Fragile X Premutation CarriersR01MH078041 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HESSL, DAVID R, RIVERA, SUSAN M · 2007 to 2017
$5.4M
Mouse Models of FXTAS: Defining Critical Periods and Molecular TargetsRL1NS062411 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERMAN, ROBERT F · 2007 to 2011
$4.2M
Development of targeted therapeutic agents for the treatment of FXTAS (2 of 6)RL1AG032119 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HAGERMAN, PAUL J · 2007 to 2011
$4.1M
Neuro Therapeutics Research Institute (1 of 6)UL1DE019583 · NIDCR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HAGERMAN, PAUL J · 2008 to 2011
$3.0M
Action tremor &dementia in male carriers of fragile XR01NS044299 · NINDS · UNIVERSITY OF COLORADO DENVER · PI GRIGSBY, JAMES P · 2003 to 2007
$2.7M
Fragile X-associated Tremor/Ataxia SyndromeR01AG024488 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI HAGERMAN, PAUL J · 2005 to 2009
$1.8M
Visual Processing and Later Cognitive Effects in Infants with fragile X SyndromeR01HD056031 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RIVERA, SUSAN M · 2007 to 2011
$1.2M
Genetics and Physiology of Social Anxiety in Fragile XK23MH077554 · NIMH · UNIVERSITY OF CALIFORNIA DAVIS · PI HESSL, DAVID R · 2005 to 2009
$772k
NCRR NIH HHS UL1 RR024146NIA NIH HHS AG024488NIA NIH HHS R01 AG024488NIA NIH HHS RL1 AG032115NIA NIH HHS RL1 AG032119NICHD NIH HHS HD02274NICHD NIH HHS HD036071NICHD NIH HHS HD056031NICHD NIH HHS P30 HD002274NICHD NIH HHS R01 HD036071NICHD NIH HHS R01 HD056031NIDCR NIH HHS UL1 DE019583NIMH NIH HHS K23 MH077554NIMH NIH HHS MH078041NIMH NIH HHS MH77554NIMH NIH HHS R01 MH078041NINDS NIH HHS NS044299NINDS NIH HHS R01 NS044299NINDS NIH HHS RL1 NS062411NINDS NIH HHS RL1NS062411
6 · The paper itself

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is an adult-onset neurodegenerative disorder generally presenting with intention tremor and gait ataxia, but with a growing list of co-morbid medical conditions including hypothyroidism, hypertension, peripheral neuropathy, and cognitive decline. The pathological hallmark of FXTAS is the presence of intranuclear inclusions in both neurons and astroglia. However, it is unknown to what extent such inclusions are present outside the central nervous system (CNS). To address this issue, we surveyed non-CNS organs in ten human cases with FXTAS and in a CGG repeat knock-in (CGG KI) mouse model known to possess neuronal and astroglial inclusions. We find inclusions in multiple tissues from FXTAS cases and CGG KI mice, including pancreas, thyroid, adrenal gland, gastrointestinal, pituitary gland, pineal gland, heart, and mitral valve, as well as throughout the associated autonomic ganglia. Inclusions were observed in the testes, epididymis, and kidney of FXTAS cases, but were not observed in mice. These observations demonstrate extensive involvement of the peripheral nervous system and systemic organs. The finding of intranuclear inclusions in non-CNS somatic organ systems, throughout the PNS, and in the enteric nervous system of both FXTAS cases as well as CGG KI mice suggests that these tissues may serve as potential sites to evaluate early intervention strategies or be used as diagnostic factors.

Indexed as

Genetic Carrier ScreeningAgedAged, 80 and overAnimalsAtaxiaDisease Models, AnimalFemaleFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeGene Knock-In TechniquesHumansMaleMiceMice, Mutant StrainsOrgan SpecificityTremorFMR1 protein, humanFmr1 protein, mouseFragile X Messenger Ribonucleoprotein 1

Identifiers

PMID21785977
PMCPMC3222079
OpenAlexW2100519086

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.